BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 22506635)

  • 1. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.
    Vazquez SE; Ferré EM; Scheel DW; Sunshine S; Miao B; Mandel-Brehm C; Quandt Z; Chan AY; Cheng M; German M; Lionakis M; DeRisi JL; Anderson MS
    Elife; 2020 May; 9():. PubMed ID: 32410729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.
    Kemp EH; Gavalas NG; Krohn KJ; Brown EM; Watson PF; Weetman AP
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4749-56. PubMed ID: 19837919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.
    Zhang L; Barker JM; Babu S; Su M; Stenerson M; Cheng M; Shum A; Zamir E; Badolato R; Law A; Eisenbarth GS; Anderson MS
    Clin Immunol; 2007 Nov; 125(2):131-7. PubMed ID: 17825626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 - A National Cohort Study.
    Laakso SM; Häkkinen A; Mäkitie O; Laakso S
    J Clin Immunol; 2024 Jun; 44(6):140. PubMed ID: 38829425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes.
    Savvateeva EN; Yukina MY; Nuralieva NF; Filippova MA; Gryadunov DA; Troshina EA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome.
    Pollock AJ; Seibert TS; Salvatori C; Caturegli P; Allen DB
    Horm Res Paediatr; 2017; 87(2):123-129. PubMed ID: 27355580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hypothalamic-Pituitary Axis and Autoantibody Related Disorders.
    Cocco C; Brancia C; Corda G; Ferri GL
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Subset of Men With Age-Related Decline in Testosterone Have Gonadotroph Autoantibodies.
    Ricciuti A; Travison TG; Di Dalmazi G; Talor MV; DeVincentiis L; Manley RW; Bhasin S; Caturegli P; Basaria S
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1535-41. PubMed ID: 26963952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations.
    Pisanu C; Cocco C; Cossu E; Baroni MG; Pigliaru F; Manetti L; Lupi I; Martino E; Mariotti S
    J Endocrinol Invest; 2014 Oct; 37(10):973-8. PubMed ID: 25070044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity in 2012.
    Selmi C
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):290-301. PubMed ID: 23975606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome?
    Cocco C; Meloni A; Boi F; Pinna G; Possenti R; Mariotti S; Ferri GL
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4108-11. PubMed ID: 15855266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.
    Smith CJ; Oscarson M; Rönnblom L; Alimohammadi M; Perheentupa J; Husebye ES; Gustafsson J; Nordmark G; Meloni A; Crock PA; Kämpe O; Bensing S
    Scand J Immunol; 2011 Feb; 73(2):147-53. PubMed ID: 21198756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Novel Clinical Entity "Anti-PIT-1 Antibody Syndrome"--Autoimmunity against a Transcription Factor].
    Takahashi Y; Bando H; Iguchi G
    Rinsho Byori; 2015 Apr; 63(4):491-7. PubMed ID: 26536783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism.
    Bando H; Iguchi G; Yamamoto M; Hidaka-Takeno R; Takahashi Y
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):290-6. PubMed ID: 25962206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1.
    Cocco C; Meloni A; Mariotti S; Cossu E; D'amato F; Zulian S; Tongiorgi E; Ferri GL
    Autoimmunity; 2012 Sep; 45(6):485-94. PubMed ID: 22506635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.
    Bensing S; Fetissov SO; Mulder J; Perheentupa J; Gustafsson J; Husebye ES; Oscarson M; Ekwall O; Crock PA; Hökfelt T; Hulting AL; Kämpe O
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):949-54. PubMed ID: 17215373
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.